Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00350
|
|||||
| Drug Name |
D-carnitine
|
|||||
| Synonyms |
(+)-Carnitine; (3S)-3-hydroxy-4-(trimethylammonio)butanoate; (3S)-3-hydroxy-4-(trimethylazaniumyl)butanoate; (S)-3-Hydroxy-4-(trimethylammonio)butanoate; CHEBI:11060; Carnitine D-form; D-(3-Carboxy-2-hydroxypropyl)trimethylammonium hydroxide, inner salt; D-carnitine; U9VY0ZOK7A; UNII-U9VY0ZOK7A
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Discovery agent [ICD11: N.A.] | Investigative | ||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C7H15NO3
|
|||||
| Canonical SMILES |
C[N+](C)(C)CC(CC(=O)[O-])O
|
|||||
| InChI |
InChI=1S/C7H15NO3/c1-8(2,3)5-6(9)4-7(10)11/h6,9H,4-5H2,1-3H3/t6-/m0/s1
|
|||||
| InChIKey |
PHIQHXFUZVPYII-LURJTMIESA-N
|
|||||
| CAS Number |
CAS 541-14-0
|
|||||
| Pharmaceutical Properties | Molecular Weight | 161.2 | Topological Polar Surface Area | 60.4 | ||
| Heavy Atom Count | 11 | Rotatable Bond Count | 3 | |||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 3 | |||
| XLogP |
-0.2
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
ChEBI:11060
|
|||||
| DT(s) Transporting This Drug | OCTN2 | Transporter Info | Organic cation/carnitine transporter 2 | Substrate | [1] | |
| Drug-Transporter Activity Data | ||||||
| Drug-Transporter Activity Data | OCTN2 | Transporter Info | Km = 10.9 microM | Human embryonic kidney cells (HEK293)-OCTN2 | [2] | |
| OCTN2 | Transporter Info | Km = 98.3 microM | Oocytes-OCTN2 | [1] | ||
| References | ||||||
| 1 | Functional and pharmacological characterization of human Na(+)-carnitine cotransporter hOCTN2. Am J Physiol Renal Physiol. 2000 Sep;279(3):F584-91. | |||||
| 2 | Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance. J Pharmacol Exp Ther. 1999 Nov;291(2):778-84. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.